0 avis
Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients
Archive ouverte : Article de revue
Edité par HAL CCSD ; Elsevier/French Society of Cardiology
International audience